Targeting Alternative Sites on the Androgen Receptor to Treat Castration-Resistant Prostate Cancer

By Lallous Nada   Dalal Kush   Cherkasov Artem   Rennie Paul S.  

International Journal of Molecular Sciences, Vol. 14, Iss. 6, 2013-06 ,pp. : 12496-12519

MDPI

Access to resources Recommend Favorite

Non-Coding RNAs in Castration-Resistant Prostate Cancer: Regulation of Androgen Receptor Signaling and Cancer Metabolism

By Shih Jing-Wen   Wang Ling-Yu   Hung Chiu-Lien   Kung Hsing-Jien   Hsieh Chia-Ling  

International Journal of Molecular Sciences, Vol. 16, Iss. 12, 2015-12 ,pp. : 28943-28978

MDPI

Access to resources Recommend Favorite

Recent Progress in Pharmaceutical Therapies for Castration-Resistant Prostate Cancer

By Yin Lina   Hu Qingzhong   Hartmann Rolf W.  

International Journal of Molecular Sciences, Vol. 14, Iss. 7, 2013-07 ,pp. : 13958-13978

MDPI

Access to resources Recommend Favorite

Epidermal Growth Factor Receptor Status in Circulating Tumor Cells as a Predictive Biomarker of Sensitivity in Castration-Resistant Prostate Cancer Patients Treated with Docetaxel Chemotherapy

By Okegawa Takatsugu   Itaya Naoshi   Hara Hidehiko   Tambo Mitsuhiro   Nutahara Kikuo  

International Journal of Molecular Sciences, Vol. 17, Iss. 12, 2016-11 ,pp. : 2008-2008

MDPI

Access to resources Recommend Favorite

Melatonin Inhibits Androgen Receptor Splice Variant-7 (AR-V7)-Induced Nuclear Factor-Kappa B (NF-κB) Activation and NF-κB Activator-Induced AR-V7 Expression in Prostate Cancer Cells: Potential Implications for the Use of Melatonin in Castration-Resistant Prostate Cancer (CRPC) Therapy

By Liu Vincent Wing Sun   Yau Wing Lung   Tam Chun Wai   Yao Kwok-Ming   Shiu Stephen Yuen Wing  

International Journal of Molecular Sciences, Vol. 18, Iss. 6, 2017-05 ,pp. : 1130-1130

MDPI

Access to resources Recommend Favorite